GR3029983T3 - Diagnosis of leishmaniasis. - Google Patents
Diagnosis of leishmaniasis.Info
- Publication number
- GR3029983T3 GR3029983T3 GR990401062T GR990401062T GR3029983T3 GR 3029983 T3 GR3029983 T3 GR 3029983T3 GR 990401062 T GR990401062 T GR 990401062T GR 990401062 T GR990401062 T GR 990401062T GR 3029983 T3 GR3029983 T3 GR 3029983T3
- Authority
- GR
- Greece
- Prior art keywords
- leishmania
- sample
- recombinant
- repeat unit
- detecting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56905—Protozoa
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/822—Protozoa
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Power Conversion In General (AREA)
- Soft Magnetic Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/006,676 US5411865A (en) | 1993-01-15 | 1993-01-15 | Method of detecting anti-leishmania parasite antibodies |
PCT/US1994/000324 WO1994016331A1 (en) | 1993-01-15 | 1994-01-10 | Diagnosis of leishmaniasis |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3029983T3 true GR3029983T3 (en) | 1999-07-30 |
Family
ID=21722052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR990401062T GR3029983T3 (en) | 1993-01-15 | 1999-04-16 | Diagnosis of leishmaniasis. |
Country Status (8)
Country | Link |
---|---|
US (2) | US5411865A (el) |
EP (1) | EP0679259B1 (el) |
AT (1) | ATE178355T1 (el) |
BR (1) | BR9405713A (el) |
DE (1) | DE69417541T2 (el) |
ES (1) | ES2129630T3 (el) |
GR (1) | GR3029983T3 (el) |
WO (1) | WO1994016331A1 (el) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2705358B1 (fr) * | 1993-05-13 | 1995-08-04 | Orstom | Procédé de culture in vitro de différents stades de parasites tissulaires, stades parasitaires obtenus et applications biologiques. |
US5912166A (en) * | 1995-04-21 | 1999-06-15 | Corixa Corporation | Compounds and methods for diagnosis of leishmaniasis |
US5834592A (en) * | 1995-09-22 | 1998-11-10 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis |
US6607731B1 (en) | 1995-09-22 | 2003-08-19 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
US6375955B1 (en) * | 1995-09-22 | 2002-04-23 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
US6365165B1 (en) | 1995-09-22 | 2002-04-02 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis |
US6500437B1 (en) | 1995-09-22 | 2002-12-31 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
US6613337B1 (en) | 1997-02-12 | 2003-09-02 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
US6638517B2 (en) | 1995-09-22 | 2003-10-28 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
US5846748A (en) * | 1996-11-15 | 1998-12-08 | The Council Of Scientific & Industrial Research | Method for diagnosing visceral leishmaniasis in a patient by identification of a new key marker namely 9-O-acetylated sialoglycoconjugate |
US6458359B1 (en) * | 1998-12-23 | 2002-10-01 | C.B.F. Leti S.A. | Chimeric gene formed by the dna sequences that encode the antigenic determinants of four proteins of l. infantum and protein encoded by said gene, and pharmacuetical composition useful for preventing and/or treating leishmaniosis in animals or humans |
US20040241168A1 (en) * | 2001-03-16 | 2004-12-02 | O'daly Jose A. | Compositions and methods for the treatment and clinical remission of psoriasis |
US6673351B1 (en) | 2001-03-16 | 2004-01-06 | Astralis, Llc | Compositions and methods for the treatment and clinical remission of psoriasis |
ES2345046T3 (es) | 2003-12-26 | 2010-09-14 | All India Institute Of Medical Sciences | Polipeptidos para el diagnostico y el tratamiento de la leishmaniosis. |
WO2006110915A2 (en) * | 2005-04-15 | 2006-10-19 | University Of Iowa Research Foundation | Vaccine formulations for leishmania |
BRPI0710155A2 (pt) | 2006-04-10 | 2011-08-23 | Infectious Disease Res Inst Inc | compostos e métodos para diagnóstico e tratamento de leishmaniose |
LT2484375T (lt) | 2006-09-26 | 2018-07-10 | Infectious Disease Research Institute | Vakcinos kompozicija, turinti sintetinio adjuvanto |
US20090181078A1 (en) * | 2006-09-26 | 2009-07-16 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
US20100304461A1 (en) * | 2007-06-12 | 2010-12-02 | Brandis John W | Portable, Temperature and Chemically Inducible Expression Vector for High Cell Density Expression of Heterologous Genes in Escherichia Coli |
US20090325204A1 (en) * | 2008-06-27 | 2009-12-31 | Reed Steven G | Compounds and methods for diagnosis and treatment of chagas disease |
US8231881B2 (en) | 2008-07-03 | 2012-07-31 | Infectious Disease Research Institute | Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
BRPI1011072B1 (pt) | 2009-06-05 | 2021-09-28 | Infectious Disease Research Institute | Composto de gla, composições de vacina e farmacêutica compreendendo dito composto, bem como uso dos mesmos para estimular, induzir ou acentuar uma resposta imune em um indivíduo |
BRPI1003744B1 (pt) * | 2010-06-08 | 2021-10-26 | Universidade Federal De Ouro Preto | E-ntpdases recombinantes, uso na produção de kit de diagnóstico para detecção de anticorpos nas leishmanioses causadas por espécies do gênero leishmania |
MX350795B (es) | 2011-04-08 | 2017-09-19 | Inmune Design Corp | Composiciones inmunogenicas y metodos para utilizar las composiciones para inducir respuestas inmunes humorales y celulares. |
ES2729967T3 (es) | 2012-02-07 | 2019-11-07 | Infectious Disease Res Inst | Formulaciones de adyuvante mejoradas que comprenden agonistas de TLR4 y métodos para usar las mismas |
PL2850431T3 (pl) | 2012-05-16 | 2018-09-28 | Immune Design Corp. | Szczepionki przeciwko HSV-2 |
EP2756850A1 (en) * | 2013-01-18 | 2014-07-23 | Philipps-Universität Marburg | Diagnosis of Leishmania infection |
ES2728865T3 (es) | 2013-03-28 | 2019-10-29 | Infectious Disease Res Inst | Vacunas que comprenden polipéptidos de Leishmania para el tratamiento y el diagnóstico de la leishmaniasis |
BR112015025709A2 (pt) | 2013-04-18 | 2017-07-18 | Immune Design Corp | monoterapia com gla para uso em tratamento de câncer |
US9463198B2 (en) | 2013-06-04 | 2016-10-11 | Infectious Disease Research Institute | Compositions and methods for reducing or preventing metastasis |
MX2016008640A (es) | 2013-12-31 | 2016-10-07 | Infectious Disease Res Inst | Formulaciones de vacuna de vial unico. |
WO2016055836A1 (pt) * | 2014-10-09 | 2016-04-14 | Universidade Federal De Minas Gerais - Ufmg | Processo de produção e uso da proteína rk39-kddr e kit para diagnóstico de leishmaniose |
EP3463300A1 (en) | 2016-06-01 | 2019-04-10 | Infectious Disease Research Institute | Nanoalum particles containing a sizing agent |
KR20220125149A (ko) | 2019-05-25 | 2022-09-14 | 액세스 투 어드밴스드 헬스 인스티튜트 | 애주번트 백신 에멀션을 분무 건조시키기 위한 조성물 및 방법 |
EP4215916A1 (de) * | 2022-01-20 | 2023-07-26 | Philipps-Universität Marburg | Test zum nachweis von antikörpern gegen leishmanien |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0197062B1 (fr) * | 1984-10-01 | 1991-01-09 | Institut Pasteur | Anticorps monoclonaux anti-leishmania, hybridomes secreteurs de ces anticorps, antigenes de leishmania reconnus par ces anticorps, procede d'obtention et applications de ces anticorps monoclonaux et de ces antigenes |
IL82740A0 (en) * | 1987-06-01 | 1987-12-20 | Yeda Res & Dev | Assay for leishmaniasis |
FR2619220B1 (fr) * | 1987-08-03 | 1993-03-26 | Pasteur Institut | Antigenes specifiques de leishmania et leur procede de preparation, profils antigeniques contenant ces antigenes et leur application au diagnostic des leishmanioses viscerales. |
GB8921937D0 (en) * | 1989-09-28 | 1989-11-15 | Howard Michael K | Diagnostic reagents for leishmaniasis |
-
1993
- 1993-01-15 US US08/006,676 patent/US5411865A/en not_active Expired - Lifetime
-
1994
- 1994-01-10 BR BR9405713A patent/BR9405713A/pt not_active Application Discontinuation
- 1994-01-10 AT AT94907184T patent/ATE178355T1/de not_active IP Right Cessation
- 1994-01-10 DE DE69417541T patent/DE69417541T2/de not_active Expired - Lifetime
- 1994-01-10 ES ES94907184T patent/ES2129630T3/es not_active Expired - Lifetime
- 1994-01-10 WO PCT/US1994/000324 patent/WO1994016331A1/en active IP Right Grant
- 1994-01-10 EP EP94907184A patent/EP0679259B1/en not_active Expired - Lifetime
- 1994-07-28 US US08/282,845 patent/US5719263A/en not_active Expired - Lifetime
-
1999
- 1999-04-16 GR GR990401062T patent/GR3029983T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0679259A4 (en) | 1997-06-18 |
EP0679259A1 (en) | 1995-11-02 |
DE69417541D1 (de) | 1999-05-06 |
US5411865A (en) | 1995-05-02 |
ES2129630T3 (es) | 1999-06-16 |
ATE178355T1 (de) | 1999-04-15 |
DE69417541T2 (de) | 1999-07-15 |
WO1994016331A1 (en) | 1994-07-21 |
BR9405713A (pt) | 1995-11-28 |
US5719263A (en) | 1998-02-17 |
EP0679259B1 (en) | 1999-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3029983T3 (en) | Diagnosis of leishmaniasis. | |
PT716697E (pt) | Genes e proteinas de leishmania expressos diferencialmente | |
AU2010288A (en) | A process for synthesising his and trp containing peptides | |
EP1264890A3 (en) | Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays | |
ES8606653A1 (es) | Un metodo para la preparacion de una proteina que esta cova-lentemente acoplada a un extremo de un acido nucleico | |
ES8801839A1 (es) | Procedimiento para detectar anticuerpos a htlv-iii y diagnosticar aids, arc o estados pre-aids | |
EP1104887A3 (en) | A method and test kit for assaying collagen fragments in body fluids | |
IL79277A0 (en) | Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein | |
EP0869177A3 (en) | Human a- and b- platelet-derived growth factor receptor proteins and uses therefor. | |
Obinata et al. | Immunochemical comparison of myosin light chains from chicken fast white, slow red, and cardiac muscle | |
ES8402939A1 (es) | Procedimiento de analisis de ligacion especifica para determinar un analito en una muestra de ensayo. | |
EP0293827A3 (en) | Assay for leishmaniasis | |
AU583598B2 (en) | Assaying method for primary amines using aromatic dialdehydes | |
EP0487621A4 (en) | Immunoassay of glycosylated proteins employing antibody directed to reductively glycosylated n-terminal amino acids | |
FR2722508B1 (fr) | Cassette d'expression d'une proteine p30 de toxoplasma gondii | |
Funk et al. | An investigation into the significance of the N-linked oligosaccharides of Leishmania gp63 | |
NZ233328A (en) | Polypeptides produced by hepatocytes infected with p. falciparum; nucleic acid probes | |
WO1995021916A3 (en) | Pp32: a newly identified cd45-associated protein | |
DE3683261D1 (de) | Plasmodium-falciparum-antigene der intraerythrocytaeren phase, ihre reinigung sowie antigen- und antikoerperbestimmung und sie enthaltende malaria-impfstoffe. | |
Michalski et al. | Molecular characterisation of peanut agglutininbinding glycoproteins from Eimeria tenella | |
CA2105538A1 (en) | Differentially Expressed Leishmania Genes and Proteins | |
Caillaud et al. | A new and highly efficient method for the peroxidase reaction in ELISA. | |
IT1189295B (it) | Composizione antigenica sintetica e procedimento per la sua preparazione | |
ES8801949A1 (es) | Un procedimiento para la preparacion de un vector de expresion que comprende un gen que codifica una proteina envolvente de un virus de sida |